Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?
Saved in:
| Title: | Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment? |
|---|---|
| Authors: | Volk A; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. an.volk@uke.de., von Bülow C; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Stern A; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Department of Internal Medicine, Southwest Healthcare, Temecula, USA., Simon R; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Burandt E; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauter G; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schmalfeldt B; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Oliveira-Ferrer L; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. |
| Source: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Jan 24; Vol. 151 (2), pp. 44. Date of Electronic Publication: 2025 Jan 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
